Does MEPOLIZUMAB Cause Therapy cessation? 333 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 333 reports of Therapy cessation have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.8% of all adverse event reports for MEPOLIZUMAB.
333
Reports of Therapy cessation with MEPOLIZUMAB
0.8%
of all MEPOLIZUMAB reports
8
Deaths
89
Hospitalizations
How Dangerous Is Therapy cessation From MEPOLIZUMAB?
Of the 333 reports, 8 (2.4%) resulted in death, 89 (26.7%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 333 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which MEPOLIZUMAB Alternatives Have Lower Therapy cessation Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE